Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial-Reference-Cited by-同舟云学术

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

Published:2014-04 Issue:4 Volume:15 Page:396-405
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Pignata Sandro,Scambia Giovanni,Katsaros Dionyssios,Gallo Ciro,Pujade-Lauraine Eric,De Placido Sabino,Bologna Alessandra,Weber Beatrice,Raspagliesi Francesco,Panici Pierluigi Benedetti,Cormio Gennaro,Sorio Roberto,Cavazzini Maria Giovanna,Ferrandina Gabriella,Breda Enrico,Murgia Viviana,Sacco Cosimo,Cinieri Saverio,Salutari Vanda,Ricci Caterina,Pisano Carmela,Greggi Stefano,Lauria Rossella,Lorusso Domenica,Marchetti Claudia,Selvaggi Luigi,Signoriello Simona,Piccirillo Maria Carmela,Di Maio Massimo,Perrone Francesco

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. First-line therapy in ovarian cancer trials;Thigpen;Int J Gynecol Cancer,2011

2. Effect of paclitaxel on vascular endothelial growth factor (VEGF) and interleukin (IL)-8 in serum of patients with recurrent ovarian cancer: a comparison of weekly vs triweekly regimens;Saito;Target Oncol,2006

3. Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer;Fennelly;J Clin Oncol,1997

4. Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study;Markman;Gynecol Oncol,2006

5. Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer;Klaassen;Eur J Cancer,1996

Cited by 329 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population;International Journal of Gynecologic Cancer;2024-09-03

2. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

3. The development of an archive of patient-reported outcome measures (PROMs) in oncology: The Italian PRO4All project;European Journal of Cancer;2024-08

4. Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial;Med;2024-08

5. Consenso de expertos basado en la evidencia: perfilamiento y manejo del carcinoma epitelial de ovario de alto grado avanzado;Revista Colombiana de Obstetricia y Ginecología;2024-06-14